X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (759) 759
Patent (189) 189
Publication (97) 97
Book Chapter (10) 10
Book Review (5) 5
Book / eBook (3) 3
Conference Proceeding (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (312) 312
oncology (272) 272
index medicus (218) 218
biochemistry (191) 191
chemistry (189) 189
metallurgy (189) 189
beer (188) 188
compositions or test papers therefor (188) 188
condition-responsive control in microbiological orenzymological processes (188) 188
enzymology (188) 188
measuring or testing processes involving enzymes, nucleicacids or microorganisms (188) 188
microbiology (188) 188
mutation or genetic engineering (188) 188
processes of preparing such compositions (188) 188
spirits (188) 188
vinegar (188) 188
wine (188) 188
female (174) 174
male (172) 172
middle aged (154) 154
aged (143) 143
colorectal cancer (124) 124
colorectal neoplasms - drug therapy (123) 123
adult (122) 122
cancer (105) 105
colorectal neoplasms - genetics (85) 85
colorectal neoplasms - pathology (85) 85
antineoplastic combined chemotherapy protocols - therapeutic use (84) 84
human necessities (82) 82
hygiene (82) 82
medical or veterinary science (82) 82
preparations for medical, dental, or toilet purposes (80) 80
antineoplastic agents - therapeutic use (79) 79
chemotherapy (78) 78
aged, 80 and over (77) 77
article (75) 75
treatment outcome (65) 65
prognosis (64) 64
organic chemistry (58) 58
pharmacology & pharmacy (55) 55
care and treatment (54) 54
expression (51) 51
bevacizumab (50) 50
survival (50) 50
disease-free survival (49) 49
cetuximab (48) 48
specific therapeutic activity of chemical compounds ormedicinal preparations (47) 47
metastasis (46) 46
tumors (44) 44
colorectal-cancer (43) 43
neoplasm metastasis (43) 43
research (43) 43
fluorouracil (42) 42
1st-line treatment (41) 41
animals (40) 40
clinical trials (40) 40
medicine & public health (39) 39
oxaliplatin (39) 39
patients (39) 39
camptothecin - analogs & derivatives (38) 38
investigating or analysing materials by determining theirchemical or physical properties (38) 38
measuring (38) 38
physics (38) 38
testing (38) 38
neoplasms - drug therapy (37) 37
colon-cancer (35) 35
fluorouracil - administration & dosage (35) 35
metastases (35) 35
colorectal carcinoma (34) 34
5-fluorouracil (32) 32
irinotecan (32) 32
mutation (32) 32
peptides (32) 32
angiogenesis (31) 31
antibodies, monoclonal - therapeutic use (31) 31
antineoplastic agents - pharmacology (30) 30
biomarkers (30) 30
colorectal neoplasms - mortality (30) 30
polymorphism, genetic (30) 30
drug therapy (29) 29
genetic aspects (29) 29
growth-factor receptor (29) 29
therapy (29) 29
thymidylate synthase (29) 29
fluorouracil - therapeutic use (28) 28
antibodies, monoclonal, humanized (27) 27
biomarkers, tumor - genetics (27) 27
breast-cancer (27) 27
neoplasm staging (27) 27
survival analysis (27) 27
antineoplastic agents - adverse effects (26) 26
nucleotides (26) 26
polymorphism, single nucleotide (26) 26
cells (25) 25
endothelial growth-factor (25) 25
nucleosides (25) 25
solid tumors (25) 25
antineoplastic agents - administration & dosage (24) 24
derivatives thereof (24) 24
gene expression (24) 24
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
International Journal of Cancer, ISSN 0020-7136, 05/2019, Volume 144, Issue 10, pp. 2567 - 2577
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2008, Volume 26, Issue 14, pp. 2311 - 2319
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2005, Volume 23, Issue 15, pp. 3536 - 3544
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 03/2018, Volume 36, Issue 8, pp. 773 - 779
PurposeNivolumab provides clinical benefit (objective response rate [ORR], 31%; 95% CI, 20.8 to 42.9; disease control rate, 69%; 12-month overall survival... 
CRITERIA | MULTICENTER | MELANOMA | SOLID TUMORS | ONCOLOGY | PD-1 BLOCKADE | OPEN-LABEL | QUALITY-OF-LIFE | DEFICIENCY | GUIDELINE
Journal Article
Molecular Cancer Therapeutics, ISSN 1535-7163, 10/2015, Volume 14, Issue 10, pp. 2401 - 2408
Journal Article